Dalby RN - Search Results

1

Targeting aerosol deposition in patients with cystic fibrosis: effects of alterations in particle size and inspiratory flow rate.

Laube BL, Jashnani R, Dalby RN, Zeitlin PL. Laube BL, et al. Among authors: dalby rn. Chest. 2000 Oct;118(4):1069-76. doi: 10.1378/chest.118.4.1069. Chest. 2000. PMID: 11035679 Clinical Trial.

2

Positive expiratory pressure changes aerosol distribution in patients with cystic fibrosis.

Laube BL, Geller DE, Lin TC, Dalby RN, Diener-West M, Zeitlin PL. Laube BL, et al. Among authors: dalby rn. Respir Care. 2005 Nov;50(11):1438-44. Respir Care. 2005. PMID: 16253150 Free article. Clinical Trial.

3

The efficacy of slow versus faster inhalation of cromolyn sodium in protecting against allergen challenge in patients with asthma.

Laube BL, Edwards AM, Dalby RN, Creticos PS, Norman PS. Laube BL, et al. Among authors: dalby rn. J Allergy Clin Immunol. 1998 Apr;101(4 Pt 1):475-83. doi: 10.1016/s0091-6749(98)70376-8. J Allergy Clin Immunol. 1998. PMID: 9564800 Free article.

4

Allergen challenge and deposition of nedocromil sodium in asthma.

Laube BL, Lin TC, Valleteau A, Dalby RN, Diemer FB, Togias AG. Laube BL, et al. Among authors: dalby rn. J Aerosol Med. 2002 Winter;15(4):415-25. doi: 10.1089/08942680260473498. J Aerosol Med. 2002. PMID: 12581508 Clinical Trial.

5

Validity of in vitro tests on aqueous spray pumps as surrogates for nasal deposition.

Suman JD, Laube BL, Lin TC, Brouet G, Dalby R. Suman JD, et al. Pharm Res. 2002 Jan;19(1):1-6. doi: 10.1023/a:1013643912335. Pharm Res. 2002. PMID: 11837692

6

The effect of formulation variables and breathing patterns on the site of nasal deposition in an anatomically correct model.

Guo Y, Laube B, Dalby R. Guo Y, et al. Pharm Res. 2005 Nov;22(11):1871-8. doi: 10.1007/s11095-005-7391-9. Epub 2005 Aug 16. Pharm Res. 2005. PMID: 16091994 Clinical Trial.

7

Comparison of nasal deposition and clearance of aerosol generated by nebulizer and an aqueous spray pump.

Suman JD, Laube BL, Dalby R. Suman JD, et al. Pharm Res. 1999 Oct;16(10):1648-52. doi: 10.1023/a:1011933410898. Pharm Res. 1999. PMID: 10554112 Clinical Trial. No abstract available.

8

Predicting in vivo lung deposition of cromolyn sodium from in vitro estimates.

Laube BL, Jashnani R, Dalby RN. Laube BL, et al. Among authors: dalby rn. J Aerosol Med. 1998;11 Suppl 1:S35-42. J Aerosol Med. 1998. PMID: 10180731 No abstract available.

9

Validity of in vitro tests on aqueous spray pumps as surrogates for nasal deposition, absorption, and biologic response.

Suman JD, Laube BL, Dalby R. Suman JD, et al. J Aerosol Med. 2006 Winter;19(4):510-21. doi: 10.1089/jam.2006.19.510. J Aerosol Med. 2006. PMID: 17196079

10

Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop Summary Report.

Adams WP, Ahrens RC, Chen ML, Christopher D, Chowdhury BA, Conner DP, Dalby R, Fitzgerald K, Hendeles L, Hickey AJ, Hochhaus G, Laube BL, Lucas P, Lee SL, Lyapustina S, Li B, O'Connor D, Parikh N, Parkins DA, Peri P, Pitcairn GR, Riebe M, Roy P, Shah T, Singh GJ, Sharp SS, Suman JD, Weda M, Woodcock J, Yu L. Adams WP, et al. J Aerosol Med Pulm Drug Deliv. 2010 Feb;23(1):1-29. doi: 10.1089/jamp.2009.0803. J Aerosol Med Pulm Drug Deliv. 2010. PMID: 20131983

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page